Pervin S, Islam M, Yorisada Y, Sakai A, Masamune S, Yabuki A
Animals (Basel). 2022; 12(10).
PMID: 35625088
PMC: 9137666.
DOI: 10.3390/ani12101242.
Rha A, Maguire A, Martin D
Appl Clin Genet. 2021; 14:209-233.
PMID: 33859490
PMC: 8044076.
DOI: 10.2147/TACG.S206076.
Eikelberg D, Lehmbecker A, Brogden G, Tongtako W, Hahn K, Habierski A
J Clin Med. 2020; 9(4).
PMID: 32252429
PMC: 7230899.
DOI: 10.3390/jcm9041004.
Latour Y, Yoon R, Thomas S, Grant C, Li C, Sena-Esteves M
Mol Genet Metab Rep. 2019; 21:100513.
PMID: 31534909
PMC: 6744524.
DOI: 10.1016/j.ymgmr.2019.100513.
Kohyama M, Yabuki A, Ochiai K, Nakamoto Y, Uchida K, Hasegawa D
BMC Vet Res. 2016; 12:67.
PMID: 27036194
PMC: 4815186.
DOI: 10.1186/s12917-016-0691-y.
Myelin abnormalities in the optic and sciatic nerves in mice with GM1-gangliosidosis.
Heinecke K, Luoma A, dAzzo A, Kirschner D, Seyfried T
ASN Neuro. 2015; 7(1).
PMID: 25694553
PMC: 4342369.
DOI: 10.1177/1759091415568913.
Serial MRI features of canine GM1 gangliosidosis: a possible imaging biomarker for diagnosis and progression of the disease.
Hasegawa D, Yamato O, Nakamoto Y, Ozawa T, Yabuki A, Itamoto K
ScientificWorldJournal. 2012; 2012:250197.
PMID: 22536126
PMC: 3334264.
DOI: 10.1100/2012/250197.
Isolation and characterization of the normal canine beta-galactosidase gene and its mutation in a dog model of GM1-gangliosidosis.
Wang Z, Zeng B, Shibuya H, Johnson G, Alroy J, Pastores G
J Inherit Metab Dis. 2000; 23(6):593-606.
PMID: 11032334
DOI: 10.1023/a:1005630013448.
Beta-galactosidase-deficient mouse as an animal model for GM1-gangliosidosis.
Matsuda J, Suzuki O, Oshima A, Ogura A, Noguchi Y, Yamamoto Y
Glycoconj J. 1997; 14(6):729-36.
PMID: 9337086
DOI: 10.1023/a:1018573518127.
A new form of ovine GM1-gangliosidosis.
Skelly B, Jeffrey M, Franklin R, Winchester B
Acta Neuropathol. 1995; 89(4):374-9.
PMID: 7610770
DOI: 10.1007/BF00309632.
A suspected new canine storage disease.
Hartley W, Canfield P, Donnelly T
Acta Neuropathol. 1982; 56(3):225-32.
PMID: 7072491
DOI: 10.1007/BF00690639.
Needs for animal models of human diseases of the nervous system.
Vogel F
Am J Pathol. 1980; 101(3 Suppl):S201-11.
PMID: 7006405
PMC: 1903615.
Inherited metabolic disease in laboratory animals: a review.
Bulfield G
J Inherit Metab Dis. 1980; 3(4):133-43.
PMID: 6787334
DOI: 10.1007/BF02312547.
Dog GM1 gangliosidosis: characterization of the residual liver acid beta-galactosidase.
Rittmann L, Tennant L, OBrien J
Am J Hum Genet. 1980; 32(6):880-9.
PMID: 6778205
PMC: 1686169.
GM1 gangliosidosis, type 2: ocular clinicopathologic correlation.
Cairns L, Green W, Singer H
Graefes Arch Clin Exp Ophthalmol. 1984; 222(2):51-62.
PMID: 6440832
DOI: 10.1007/BF02150632.
Dog and human acid beta-D-galactosidases are structurally similar.
Hubert J, OBrien J
Biochem J. 1983; 213(2):473-8.
PMID: 6412684
PMC: 1152150.
DOI: 10.1042/bj2130473.
A canine model of human alpha-L-iduronidase deficiency.
Spellacy E, Shull R, CONSTANTOPOULOS G, Neufeld E
Proc Natl Acad Sci U S A. 1983; 80(19):6091-5.
PMID: 6412235
PMC: 534366.
DOI: 10.1073/pnas.80.19.6091.
Separation of beta-D-galactosidases in rabbit tissues: genetics of neutral beta-D-galactosidase.
van Zutphen L, den Bieman M, Fox R
Biochem Genet. 1983; 21(1-2):177-89.
PMID: 6404244
DOI: 10.1007/BF02395402.
GM1 gangliosidosis (type 1) in a cat.
Barker C, Blakemore W, Dell A, Palmer A, TILLER P, Winchester B
Biochem J. 1986; 235(1):151-8.
PMID: 3091002
PMC: 1146662.
DOI: 10.1042/bj2350151.
Canine GM1-gangliosidosis. A clinical, morphologic, histochemical, and biochemical comparison of two different models.
Alroy J, Orgad U, deGasperi R, Richard R, Warren C, Knowles K
Am J Pathol. 1992; 140(3):675-89.
PMID: 1546746
PMC: 1886155.